Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-14

Clinical Trial Update: GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL) [Phase 3]

View source ↗

Summary

Phase 3 trial updates for GP2013 in previously untreated, advanced follicular lymphoma have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GP2013 (rituximab biosimilar)

Snippet

Sponsor: Sandoz | Conditions: Follicular Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2021-05-14